{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06323174",
            "orgStudyIdInfo": {
                "id": "NN9388-4895"
            },
            "secondaryIdInfos": [
                {
                    "id": "2022-502677-42",
                    "type": "OTHER",
                    "domain": "European Medical Agency (EMA)"
                },
                {
                    "id": "U1111-1283-0404",
                    "type": "OTHER",
                    "domain": "World Health Organization (WHO)"
                }
            ],
            "organization": {
                "fullName": "Novo Nordisk A/S",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise",
            "officialTitle": "Efficacy and Safety of Co-administered Cagrilintide and Semaglutide (CagriSema) s.c. in Doses 2.4 mg/2.4 mg and 1.0 mg/1.0 mg Once Weekly Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Diet and Exercise",
            "acronym": "REIMAGINE 1",
            "therapeuticArea": [
                "Endocrinology"
            ],
            "study": "a-research-study-to-see-how-much-cagrisema-lowers-blood-sugar-and-body-weight-compared-to-placebo-in-people-with-type-diabetes-treated-with-diet-and-exercise"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-03-19",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-10-07",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-03-15",
            "studyFirstSubmitQcDate": "2024-03-15",
            "studyFirstPostDateStruct": {
                "date": "2024-03-21",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-16",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-17",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Novo Nordisk A/S",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study will look at how much CagriSema helps participants with type 2 diabetes lower their blood sugar and body weight. CagriSema is a new investigational medicine. Doctors may not yet prescribe CagriSema. CagriSema will be compared to a \"dummy\" medicine (also called \"placebo\") that has no effect on the body. Participants will get either CagriSema or \"dummy\" medicine. Which treatment participants get is decided by chance. For each participant, the study will last for about one year."
        },
        "conditionsModule": {
            "conditions": [
                "Type 2 Diabetes"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 180,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "CagriSema Dose 2",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Participants will receive once-weekly subcutaneous (s.c) injections of CagriSema (cagrilintide and semaglutide) at escalating doses every week in 16-week dose escalation period until target dose (dose 2) of CagriSema (cagrilintide and semaglutide) is achieved and maintained up to 24 weeks.",
                    "interventionNames": [
                        "Drug: Cagrilintide",
                        "Drug: Semaglutide"
                    ]
                },
                {
                    "label": "Placebo Dose 2",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Participants will receive once-weekly s.c injection of placebo matched to Cagrisema (cagrilintide and semaglutide) dose 2 for 40 weeks.",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                },
                {
                    "label": "Cagrisema Dose 1",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Participants will receive once-weekly subcutaneous (s.c) injections of CagriSema (cagrilintide and semaglutide) at escalating doses every week in 8-week dose escalation period until target dose (dose 1) of CagriSema (cagrilintide and semaglutide) is achieved and maintained up to 32 weeks.",
                    "interventionNames": [
                        "Drug: Cagrilintide",
                        "Drug: Semaglutide"
                    ]
                },
                {
                    "label": "Placebo Dose 1",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Participants will receive once-weekly s.c injection of placebo matched to Cagrisema (cagrilintide and semaglutide) dose 1 for 40 weeks.",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Cagrilintide",
                    "description": "Participants will receive once-weekly cagrilintide subcutaneously.",
                    "armGroupLabels": [
                        "CagriSema Dose 2",
                        "Cagrisema Dose 1"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Semaglutide",
                    "description": "Participants will receive once-weekly semaglutide subcutaneously.",
                    "armGroupLabels": [
                        "CagriSema Dose 2",
                        "Cagrisema Dose 1"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Participants will receive placebo matched to cagrilintide and semaglutide subcutaneously.",
                    "armGroupLabels": [
                        "Placebo Dose 1",
                        "Placebo Dose 2"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in glycated haemoglobin (HbA1c)",
                    "description": "Measured as percentage (%)-points.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 40)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Relative change in body weight",
                    "description": "Measured in %.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 40)"
                },
                {
                    "measure": "Number of participants who achieve greater than or equal to (>=) 10% body weight reduction",
                    "description": "Measured as count of participants.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 40)"
                },
                {
                    "measure": "Number of participants who achieve >=15% body weight reduction",
                    "description": "Measured as count of participants.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 40)"
                },
                {
                    "measure": "Number of participants who achieve HbA1c target values of less than (<) 7.0% (<53 millimoles per mole [mmol/mol])",
                    "description": "Measured as count of participants.",
                    "timeFrame": "At end of treatment (week 40)"
                },
                {
                    "measure": "Number of participants who achieve HbA1c target values of less than or equal to (<=) 6.5% (<= 48 mmol/mol)",
                    "description": "Measured as count of participants.",
                    "timeFrame": "At end of treatment (week 40)"
                },
                {
                    "measure": "Change in Fasting Plasma Glucose (FPG)",
                    "description": "Measured in millimoles per liter (mmol/L).",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 40)"
                },
                {
                    "measure": "Number of participants who achieve >=5% body weight reduction",
                    "description": "Measured as count of participants.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 40)"
                },
                {
                    "measure": "Number of participants who achieve >=20% body weight reduction",
                    "description": "Measured as count of participants.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 40)"
                },
                {
                    "measure": "Change in waist circumference",
                    "description": "Measured in centimeters (cm).",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 40)"
                },
                {
                    "measure": "Change in systolic blood pressure (SBP)",
                    "description": "Measured in millimeters of mercury (mmHg).",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 40)"
                },
                {
                    "measure": "Change in diastolic blood pressure (DBP)",
                    "description": "Measured in mmHg.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 40)"
                },
                {
                    "measure": "Ratio to baseline in high sensitivity C-reactive protein (hsCRP)",
                    "description": "Measured as ratio.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 40)"
                },
                {
                    "measure": "Ratio to baseline in lipids: Total cholesterol",
                    "description": "Measured as ratio.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 40)"
                },
                {
                    "measure": "Ratio to baseline in lipids: High-density lipoprotein (HDL) cholesterol",
                    "description": "Measured as ratio.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 40)"
                },
                {
                    "measure": "Ratio to baseline in lipids: Low-density lipoprotein (LDL) cholesterol",
                    "description": "Measured as ratio.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 40)"
                },
                {
                    "measure": "Ratio to baseline in lipids: Very low-density lipoprotein (VLDL) cholesterol",
                    "description": "Measured as ratio.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 40)"
                },
                {
                    "measure": "Ratio to baseline in lipids: Triglycerides",
                    "description": "Measured as ratio.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 40)"
                },
                {
                    "measure": "Ratio to baseline in lipids: Free fatty acids",
                    "description": "Measured as ratio.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 40)"
                },
                {
                    "measure": "Ratio to baseline in lipids: Non-HDL cholesterol",
                    "description": "Measured as ratio.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 40)"
                },
                {
                    "measure": "Number of participants who achieve type 2 diabetes (T2D) remission (HbA1c <6.5% and no antidiabetic medication)",
                    "description": "Measured as count of participants.",
                    "timeFrame": "At end of study (week 52)"
                },
                {
                    "measure": "Ratio to baseline in oral glucose tolerance test (OGTT) based oral glucose disposition index (DIo)",
                    "description": "Measured as ratio.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 40)"
                },
                {
                    "measure": "Change in experienced level of energy as measured by the SF-36v2 Health Survey Acute (SF-36v2) Vitality score",
                    "description": "Measured as score points. SF-36v2 Acute measures Health-Related Quality of Life (HRQoL). The measure consists of 36 items yielding 8 health domain scores and 2 component summary scores. SF-36v2 Acute scores are norm-based scores, that is. transformed to a scale where the 2009 US general population has a mean of 50 and a standard deviation of 10.\n\nHigher scores indicate better functional health and well-being. The vitality score range is from 25.6 to 69.1.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 40)"
                },
                {
                    "measure": "Change in SF-36v2 score: Physical Component Summary score",
                    "description": "Measured as score points. SF-36v2 Acute measures HRQoL. The measure consists of 36 items yielding 8 health domain scores and 2 component summary scores. SF-36v2 Acute scores are norm-based scores, that is. transformed to a scale where the 2009 US general population has a mean of 50 and a standard deviation of 10. Higher scores indicate better functional health and well-being. The score range for physical component summary is 6.1 to 79.7.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 40)"
                },
                {
                    "measure": "Change in SF-36v2 score: Mental Component Summary score",
                    "description": "Measured as score points. SF-36v2 Acute measures HRQoL. The measure consists of 36 items yielding 8 health domain scores and 2 component summary scores. SF-36v2 Acute scores are norm-based scores, that is. transformed to a scale where the 2009 US general population has a mean of 50 and a standard deviation of 10. Higher scores indicate better functional health and well-being. The score range for mental component summary score is -3.8 to 78.7.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 40)"
                },
                {
                    "measure": "Change in Diabetes Treatment Satisfaction Questionnaire (DTSQ) score",
                    "description": "Measured as score points. DTSQs measures treatment satisfaction and diabetes-specific quality of life. The measure consists of 8 items yielding 1 global score and 2 single item scores. Higher scores on the global score indicate greater satisfaction with treatment. Lower scores on the single-item scores indicate BG levels closer to the ideal, while higher scores indicate problems. Single-item scores (score range): Perceived frequency of hyperglycaemia (0-6), Perceived frequency of hypoglycaemia (0-6). Global score (score range): Total Treatment Satisfaction (0-36).",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 40)"
                },
                {
                    "measure": "Change in leptin",
                    "description": "Measured in nanograms per milliliter (ng/mL).",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 40)"
                },
                {
                    "measure": "Change in soluble leptin receptor",
                    "description": "Measured in ng/mL.",
                    "timeFrame": "From baseline (week 0) to end of treatment (week 40)"
                },
                {
                    "measure": "Number of Treatment Emergent Adverse Events (TEAEs)",
                    "description": "Measured as count of events.",
                    "timeFrame": "From baseline (week 0) to end of treatment +7 weeks (week 47)"
                },
                {
                    "measure": "Number of clinically significant hypoglycaemic episodes (level 2) (<3.0 mmol (54 milligrams per deciliter [mg/dL]), confirmed by blood glucose (BG) meter",
                    "description": "Measured as count of episodes.",
                    "timeFrame": "From baseline (week 0) to end of treatment +7 weeks (week 47)"
                },
                {
                    "measure": "Number of severe hypoglycaemic episodes (level 3): hypoglycaemia associated with severe cognitive impairment requiring external assistance for recovery, with no specific glucose threshold",
                    "description": "Measured as count of episodes.",
                    "timeFrame": "From baseline (week 0) to end of treatment + 7 weeks (week 47)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or female\n* Age 18 years or above at the time of signing the informed consent\n* Diagnosed with type 2 diabetes \\>=30 days before screening\n* HbA1c 7.0-9.5 percent (53-80 millimoles per mole \\[mmol/mol\\]) (both inclusive) as determined by central laboratory at screening\n* Body mass index (BMI) \\>=23 kilograms per square meter (kg/m\\^2) at screening. BMI will be calculated in the electronic case report form (eCRF) based on height and body weight at screening\n\nExclusion Criteria:\n\n* Female who is pregnant, breast-feeding or intends to become pregnant or is of childbearing potential and not using a highly effective contraceptive method\n* Renal impairment with estimated Glomerular Filtration Rate less than 30 milliliter per minute per 1.73 square meter (ml/min/1.73 m\\^2) as determined by central laboratory at screening\n* Treatment with any medication for the indication of diabetes or obesity within 90 days before screening. However, short term insulin treatment for a maximum of 14 consecutive days and prior insulin treatment for gestational diabetes are allowed\n* History of use of any injectable therapy for diabetes or obesity. However, short term insulin treatment for a maximum of 14 consecutive days and prior insulin treatment for gestational diabetes are allowed\n* Uncontrolled and potentially unstable diabetic retinopathy or maculopathy. Verified by a fundus examination performed within 90 days before screening or in the period between screening and randomisation. Pharmacological pupil-dilation is a requirement unless using a digital fundus photography camera specified for non-dilated examination",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Novo Nordisk",
                    "role": "CONTACT",
                    "phone": "(+1) 866-867-7178",
                    "email": "clinicaltrials@novonordisk.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Clinical Transparency (dept. 2834)",
                    "affiliation": "Novo Nordisk A/S",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "National Research Institute_Huntington Park",
                    "status": "RECRUITING",
                    "city": "Huntington Park",
                    "state": "California",
                    "zip": "90255",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.98168,
                        "lon": -118.22507
                    }
                },
                {
                    "facility": "Valley Clinical Trials, Inc.",
                    "status": "RECRUITING",
                    "city": "Northridge",
                    "state": "California",
                    "zip": "91325",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.22834,
                        "lon": -118.53675
                    }
                },
                {
                    "facility": "Southern California Dermatology",
                    "status": "RECRUITING",
                    "city": "Santa Ana",
                    "state": "California",
                    "zip": "92701",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.74557,
                        "lon": -117.86783
                    }
                },
                {
                    "facility": "Encore Medical Research LLC",
                    "status": "RECRUITING",
                    "city": "Hollywood",
                    "state": "Florida",
                    "zip": "33024",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 26.0112,
                        "lon": -80.14949
                    }
                },
                {
                    "facility": "Alliance for Multispec Res",
                    "status": "RECRUITING",
                    "city": "Newton",
                    "state": "Kansas",
                    "zip": "67114",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.04668,
                        "lon": -97.34504
                    }
                },
                {
                    "facility": "Brigham & Women's Hospital",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02115",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Arcturus Healthcare, PLC",
                    "status": "RECRUITING",
                    "city": "Troy",
                    "state": "Michigan",
                    "zip": "48098",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.60559,
                        "lon": -83.14993
                    }
                },
                {
                    "facility": "Holston Medical Group",
                    "status": "RECRUITING",
                    "city": "Kingsport",
                    "state": "Tennessee",
                    "zip": "37660",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.54843,
                        "lon": -82.56182
                    }
                },
                {
                    "facility": "Velocity Clinical Res-Dallas",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75230",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "Northeast Clinical Research of San Antonio",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78233",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                },
                {
                    "facility": "Consano Clinical Research, LLC",
                    "status": "RECRUITING",
                    "city": "Shavano Park",
                    "state": "Texas",
                    "zip": "78231",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.58495,
                        "lon": -98.55252
                    }
                },
                {
                    "facility": "Consano Clinical Research, LLC",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Shavano Park",
                    "state": "Texas",
                    "zip": "78231",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.58495,
                        "lon": -98.55252
                    }
                },
                {
                    "facility": "TPMG Clinical Research",
                    "status": "RECRUITING",
                    "city": "Newport News",
                    "state": "Virginia",
                    "zip": "23606",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 37.08339,
                        "lon": -76.46965
                    }
                },
                {
                    "facility": "Chinese People's Liberation Army General Hospital",
                    "status": "RECRUITING",
                    "city": "Beijing",
                    "state": "Beijing",
                    "zip": "100853",
                    "country": "China",
                    "geoPoint": {
                        "lat": 39.9075,
                        "lon": 116.39723
                    }
                },
                {
                    "facility": "The Second Affiliated Hospital of Nanjing Medical University_Nanjing",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Nanjing",
                    "state": "Jiangsu",
                    "zip": "210011",
                    "country": "China",
                    "geoPoint": {
                        "lat": 32.06167,
                        "lon": 118.77778
                    }
                },
                {
                    "facility": "The Affiliated Hospital of Jiangsu University_Zhenjiang",
                    "status": "RECRUITING",
                    "city": "Zhenjiang",
                    "state": "Jiangsu",
                    "zip": "212001",
                    "country": "China",
                    "geoPoint": {
                        "lat": 32.21086,
                        "lon": 119.45508
                    }
                },
                {
                    "facility": "Jinan Central Hospital",
                    "status": "RECRUITING",
                    "city": "Ji'Nan",
                    "state": "Shandong",
                    "zip": "250000",
                    "country": "China",
                    "geoPoint": {
                        "lat": 36.66833,
                        "lon": 116.99722
                    }
                },
                {
                    "facility": "Belinus Bt.",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Debrecen",
                    "state": "Hajdu-Bihar Varmegye",
                    "zip": "4025",
                    "country": "Hungary",
                    "geoPoint": {
                        "lat": 47.53333,
                        "lon": 21.63333
                    }
                },
                {
                    "facility": "Borb\u00e1nya Praxis E.\u00dc. Kft.",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Ny\u00edregyh\u00e1za",
                    "state": "Szabolcs-Szatmar Varmegye",
                    "zip": "4405",
                    "country": "Hungary",
                    "geoPoint": {
                        "lat": 47.95539,
                        "lon": 21.71671
                    }
                },
                {
                    "facility": "Azienda Ospedaliera Papa Giovanni XXIII",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Bergamo",
                    "zip": "24127",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.69601,
                        "lon": 9.66721
                    }
                },
                {
                    "facility": "Policlinico Mater Domini Universit\u00e0 di Catanzaro",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Catanzaro",
                    "zip": "88100",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 38.88247,
                        "lon": 16.60086
                    }
                },
                {
                    "facility": "IRCCS Ospedale San Raffaele Milano",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Milano",
                    "zip": "20132",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.46427,
                        "lon": 9.18951
                    }
                },
                {
                    "facility": "Azienda Ospealiero Universitaria Policlinico Umberto I",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Roma",
                    "zip": "00161",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 41.89193,
                        "lon": 12.51133
                    }
                },
                {
                    "facility": "Centrum Medyczne Medyk Sp. z o.o.",
                    "status": "RECRUITING",
                    "city": "Rzeszow",
                    "state": "Podkarpackie",
                    "zip": "35-055",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 50.04132,
                        "lon": 21.99901
                    }
                },
                {
                    "facility": "Renew Clinic Sp. z o.o.",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Bia\u0142ystok",
                    "zip": "15-797",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 53.13333,
                        "lon": 23.16433
                    }
                },
                {
                    "facility": "Centrum Terapii Wspolczesnej",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Lodz",
                    "zip": "90-338",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 51.75,
                        "lon": 19.46667
                    }
                },
                {
                    "facility": "NBR Polska Tomasz Klodawski",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Warszawa",
                    "zip": "00-710",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 52.22977,
                        "lon": 21.01178
                    }
                },
                {
                    "facility": "King Abdulaziz Hospital-Al Ahsa-National Guard",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Al Ahsa",
                    "zip": "36428",
                    "country": "Saudi Arabia"
                },
                {
                    "facility": "National Guard Hospital - Jeddah",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Jeddah",
                    "zip": "21423",
                    "country": "Saudi Arabia",
                    "geoPoint": {
                        "lat": 21.54238,
                        "lon": 39.19797
                    }
                },
                {
                    "facility": "King Fahad Medical City",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Riyadh",
                    "zip": "11525",
                    "country": "Saudi Arabia",
                    "geoPoint": {
                        "lat": 24.68773,
                        "lon": 46.72185
                    }
                },
                {
                    "facility": "King Khaled University Hospital,King Saud Univ. Med. City",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Riyadh",
                    "zip": "12372",
                    "country": "Saudi Arabia",
                    "geoPoint": {
                        "lat": 24.68773,
                        "lon": 46.72185
                    }
                },
                {
                    "facility": "King Salman Bin Abdulaziz Hospital",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Riyadh",
                    "zip": "12769",
                    "country": "Saudi Arabia",
                    "geoPoint": {
                        "lat": 24.68773,
                        "lon": 46.72185
                    }
                },
                {
                    "facility": "CHC Zvezdara, Clinical department for endocrinology",
                    "status": "RECRUITING",
                    "city": "Belgrade",
                    "zip": "11000",
                    "country": "Serbia",
                    "geoPoint": {
                        "lat": 44.80401,
                        "lon": 20.46513
                    }
                },
                {
                    "facility": "Clinical Hospital Center Bezanijska Kosa",
                    "status": "RECRUITING",
                    "city": "Belgrade",
                    "zip": "11080",
                    "country": "Serbia",
                    "geoPoint": {
                        "lat": 44.80401,
                        "lon": 20.46513
                    }
                },
                {
                    "facility": "Clinical Hospital Centre Zemun",
                    "status": "RECRUITING",
                    "city": "Belgrade",
                    "zip": "11080",
                    "country": "Serbia",
                    "geoPoint": {
                        "lat": 44.80401,
                        "lon": 20.46513
                    }
                },
                {
                    "facility": "Policlinic for diabetes",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Zajecar",
                    "zip": "19000",
                    "country": "Serbia",
                    "geoPoint": {
                        "lat": 43.90358,
                        "lon": 22.26405
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "According to the Novo Nordisk disclosure commitment on novonordisk-trials.com.",
            "url": "http://novonordisk-trials.com"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003920",
                    "term": "Diabetes Mellitus"
                },
                {
                    "id": "D000003924",
                    "term": "Diabetes Mellitus, Type 2"
                }
            ],
            "ancestors": [
                {
                    "id": "D000044882",
                    "term": "Glucose Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7119",
                    "name": "Diabetes Mellitus, Type 2",
                    "asFound": "Type 2 Diabetes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5114",
                    "name": "Body Weight",
                    "relevance": "LOW"
                },
                {
                    "id": "M7115",
                    "name": "Diabetes Mellitus",
                    "asFound": "Diabetes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M25403",
                    "name": "Glucose Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000591245",
                    "term": "Semaglutide"
                }
            ],
            "ancestors": [
                {
                    "id": "D000097789",
                    "term": "Glucagon-Like Peptide-1 Receptor Agonists"
                },
                {
                    "id": "D000007004",
                    "term": "Hypoglycemic Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M353561",
                    "name": "Semaglutide",
                    "asFound": "Stretching",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9043",
                    "name": "Glucagon",
                    "relevance": "LOW"
                },
                {
                    "id": "M26997",
                    "name": "Glucagon-Like Peptide 1",
                    "relevance": "LOW"
                },
                {
                    "id": "M3401",
                    "name": "Glucagon-Like Peptide-1 Receptor Agonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M10054",
                    "name": "Hypoglycemic Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Hypo",
                    "name": "Hypoglycemic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                }
            ]
        }
    },
    "hasResults": false
}